Paradeep Phosphates approves 20 lakh stock options in new 2026 plan
Paradeep Phosphates Limited's Board approved the PSOP 2026, creating a pool of 20 lakh stock options for employees. With a face value of ₹10 per share, the plan includes vesting periods of up to three years and requires shareholder ratification.
*this image is generated using AI for illustrative purposes only.
The Board of Directors of Paradeep Phosphates Limited approved the introduction of the 'Paradeep Phosphates Limited Performance Stock Option Plan 2026' (PSOP 2026) during a meeting held on July 28, 2026. The proposal, recommended by the Nomination and Remuneration Committee, aims to align employee incentives with organizational growth by granting stock options to eligible personnel. The scheme is subject to final approval by the company's shareholders.
The approval was made pursuant to Regulation 30 read with Para B of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). The details were disclosed to the National Stock Exchange of India Limited and BSE Limited in accordance with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The Board meeting commenced at 2:00 P.M. (IST) and concluded at 5:00 P.M. (IST).
Plan Structure and Eligibility
The PSOP 2026 covers a total of 20,00,000 (Twenty Lakhs) stock options, which are exercisable into not more than 20,00,000 Equity Shares. Each share has a face value of ₹10/- (Rupee Ten Only) and is fully paid-up. The scheme is administered by the Committee authorized by the Board, which will determine eligibility based on roles that have a high impact on the organization's growth phase.
| Parameter | Details |
|---|---|
| Total Options | 20,00,000 Stock Options |
| Share Face Value | ₹10/- |
| Vesting Period | Minimum 1 year; Maximum 3 years |
| Exercise Period | Not more than 2 years from vesting |
Pricing and Vesting Terms
The exercise price for the options shall be the face value of the equity shares on the date of grant, or as decided by the Committee under the Companies Act and SEBI (SBEB and SE) Regulations. In no case will the exercise price be lower than the face value of the equity shares on the date of grant. Different exercise prices may apply to different sets of employees for options granted on the same or different dates.
Vesting terms stipulate a minimum period of one year between the grant and vesting of options. The maximum vesting period may extend up to three years, or such other period as decided by the Committee. Vesting may occur in one or more tranches. Once vested, the options must be exercised within a period not exceeding two years from the date of respective vesting.
Administrative Framework
The PSOP 2026 will be implemented by the Board of Directors or the Compensation/Nomination & Remuneration Committee in compliance with the Companies Act, 2013, and applicable laws. All questions regarding the interpretation of the plan will be determined by the Board or the Committee, and such determinations will be final and binding upon all interested parties. The diluted earnings per share will be determined upon the exercise of these options.
Historical Stock Returns for Paradeep Phosphates
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.39% | +0.71% | +3.49% | +9.04% | -30.11% | +217.11% |
How might the dilution of up to 20 lakh equity shares impact Paradeep Phosphates' earnings per share (EPS) and overall shareholder value in the short term?
What specific performance metrics or growth targets will the Compensation Committee use to determine eligibility for high-impact roles under the PSOP 2026?
Will the introduction of this stock option plan signal an intent to accelerate expansion projects or market share gains in the phosphate sector over the next three years?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
